For over 20 years, Martin Biel has been a full professor and Chair of Pharmacology at Ludwig-Maximilians-Universität, Munich. He is a world-renowned expert in disease mechanisms, gene functions and therapies. Martin is the co-founder and co-speaker of the German retinal gene therapy consortium RD-CURE, he co-led the first ophthalmic gene therapy program from his lab to clinical trials in Germany. He has authored over 160 original publications, over 60 reviews and book chapters. Martin is a member of the Leopoldina German National Academy of Sciences and a member of the Bavarian Academy of Sciences.
Martin studied pharmaceutical sciences at Saarland University, where he also gained his Ph.D. He completed his postdoctoral fellowship at Technical University Munich and he also holds an honorary professorship of Fudan University, Shanghai.